Sharechat Logo

Delegat's stock gains on record earnings

Thursday 28th August 2008

Text too small?
Shares of Delegat's Group, producer of Oyster Bay wine, rose 5.4% after the company posted record earnings and raised its final dividend.

The stock rose 12 cents to NZ$2.35, paring its decline this year to 11%. Net profit rose to NZ$19.1 million from NZ$10.8 million a year earlier, the company said in a statement today.

Delegat's has benefited from rising demand for New Zealand wines in the Europe, North America and Asia that helped exporters make a record NZ$800 million of sales in the latest year. The company's own sales rose 17% to 1.44 million cases.

Increasing demand for Oyster Bay wine "positions the group well for future growth," chairman Robert Wilton said.

Sales rose 23% to NZ$165 million.

The company increased its harvest, reflecting new plantings and favorable growing conditions, especially for Sauvignon Blanc from the Marlborough region. That variety is Delegat's biggest seller globally.

The company will pay a dividend of six cents a share, up from 4.5 cents in the previous year.

Shares of Oyster Bay Marlborough Vineyards, the grape grower established and 50.1% owned by Delegat's, jumped 9.9% to NZ$3.00.

By Jonathan Underhill



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors